Table 1.

Patient characteristics at baseline

CharacteristicN
Total no. of patients20
Sex
Male5
Female15
Age, y
Median69
Range58–83
ECOG performance status
010
110
Smoking history
Never15
Ever5
Clinical stage
IIIA2
IIIB3
IV15
No. of prior chemotherapy
010
16
22
31
41
EGFR mutation status
Exon 196
Exon 215
Exon 181
Wild-type3
Not determined1
Not tested4
Baseline study
 No. of target lesions
  Median2.5
  Range1–5
 SUV of target lesions
  Median5.9
  Range1.6–13.0
 Size of target lesions, cm
  Median2.0
  Range1.2–7.7